Under construction – not a live service
Sign in
Taking people in SpainNo phase

Nutrition Care for People With Type 2 Diabetes Who Are Malnourished or at Risk

Describes adults with diabetes and malnutrition risk who are prescribed a nutritional supplement drink.

Plain-language title generated from the registry record
Registry title: Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice

Key facts

Where
Huelva, Las Palmas de Gran Canaria, Madrid, Málaga, Oviedo, Santander, Seville, and Valencia, SpainSee the 12 sites

Where in Spain

  • Hospital Universitario Juan Ramon JimenezHuelva, SpainTaking people
  • Hospital UniversitarioDoctor NegrínLas Palmas de Gran Canaria, SpainTaking people
  • Hospital Clínico San CarlosMadrid, SpainTaking people
  • Hospital La PrincesaMadrid, SpainTaking people
  • Hospital Universitario La PazMadrid, SpainTaking people
  • Hospital Virgen de la VictoriaMálaga, SpainTaking people
  • Hospital Universitario Central De AsturiasOviedo, SpainTaking people
  • Hospital Universitario Marqués de ValdecillaSantander, SpainTaking people
  • Hospital Universitario Virgen de la MacarenaSeville, SpainTaking people
  • Hospital Universitario Virgen del RocioSeville, SpainTaking people
  • Hospital General de ValenciaValencia, SpainTaking people
  • Hospital La FeValencia, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Outcomes'10
Trial code
NCT07252765
Record updated
28 January 2026
Original description
The objective of this observational study is to characterize the patient profile and nutritional treatment patterns of individuals with type 2 diabetes (T2D) or drug-induced diabetes who present with malnutrition, or are at risk of it, and who are prescribed a diabetes-specific oral nutritional supplement (ONS) that is high in calories and protein and contains soluble fiber.Read full original descriptionShow less

Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice. STARLIGHT Study

The objective of this observational study is to characterize the patient profile and nutritional treatment patterns of individuals with type 2 diabetes (T2D) or drug-induced diabetes who present with malnutrition, or are at risk of it, and who are prescribed a diabetes-specific oral nutritional supplement (ONS) that is high in calories and protein and contains soluble fiber.

Participants will complete a series of questionnaires during visits 1 and 3.

Inclusion: Adult patients diagnosed with type 2 diabetes (T2D) or drug-induced diabetes; Patients at nutritional risk according to MUST or presenting malnutrition according to GLIM criteria; Patients requiring a diabetes-specific oral nutritional supplement (ONS) that is high-calorie, high-protein, and contains soluble fiber in real-world clinical practice, and who have been prescribed such a supplement within the previous 7 days; Patients able to provide informed consent and complete the study questionnaires.

Exclusion: Patients currently receiving or expected to receive other types of nutritional interventions involving supplements (oral or otherwise) or non-conventional feeding methods (e.g., feeding tubes); Patients expected to undergo any surgical intervention or require hospitalization due to a condition unrelated to the study during the study period; Patients with other conditions that, in the investigator's opinion, may interfere with adherence to the intervention or with study procedures; Patients with a history of metabolic/endocrine diseases (other than diabetes) or any other condition causing liver or kidney failure, defined as ALT > 3x ULN or eGFR < 30 ml/min/1.73 m², and according to the investigator's judgment; Patients participating in other studies or clinical trials related to malnutrition, or who, in the investigator's opinion, may alter the course of the study.

ClinicalTrials.gov NCT07252765